KalVista Pharmaceuticals logo
KalVista Pharmaceuticals KALV
$ 8.47 4.7%

Quarterly report 2024-Q3
added 12-05-2024

report update icon

KalVista Pharmaceuticals Long Term Debt Current 2011-2024 | KALV

Annual Long Term Debt Current KalVista Pharmaceuticals

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
863 K 588 K - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
863 K 588 K 726 K